Name: Joint Pain Injection Market Size, Share, Industry, Forecast and outlook (2023-2030)
Brand: DataM Intelligence
SKU: MD4834
Price: 4350 USD
Availability: InStock

Joint Pain Injection Market Size, Share, Growth and Forecast 2023-2030

Joint Pain Injection Market Size, Share, Industry, Forecast and outlook (2023-2030)

<h2>Global Joint Pain Injections Market is segmented&nbsp;By Product (Pre-filled injections,&nbsp;Vials), By Injection Type (Corticosteroid Injections,&nbsp;Hyaluronic Acid Injections,&nbsp;Platelets Rich Plasma Injections,&nbsp;Others),&nbsp;By Joint Type (Knee and Ankle,&nbsp;Hip,&nbsp;Shoulder and Elbow,&nbsp;Others),&nbsp;By End User (Hospitals Pharmacies 
Online Pharmacies,&nbsp;Retail Pharmacies,&nbsp;Others), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) &ndash; Share, Size, Outlook, and Opportunity Analysis, 2023-2030</h2>

<h2>&nbsp;</h2>

<h2>Market- Overview</h2>

<blockquote>
The global joint pain injections market&nbsp;is estimated to reach, growing at a <a href="https://www.datamintelligence.com/research-report/joint-pain-injection-market">CAGR of 6.8%</a> during the forecast period (2023-2030).&nbsp; &nbsp;&nbsp;&nbsp;
</blockquote>

A joint injection (intra-articular injection) is a medical procedure used to treat inflammatory joint disorders such as rheumatoid arthritis, psoriatic arthritis, gout, tendinitis, bursitis, Carpal Tunnel Syndrome, and osteoarthritis. A hypodermic needle is inserted into the afflicted joint, delivering a dosage of anti-inflammatory medication, the most frequent of which are corticosteroids. Because of its high viscosity, hyaluronic acid is sometimes used to replace bursa fluids. The procedure can also be done to remove excess fluid from the joint.

<h2>Market Dynamics</h2>

The growing prevalence of obesity in the population is expected to increase the use of these injections. Factors such as an increase in sedentary behavior and an aging population in both developed and developing countries are expected to increase the use of intra-articular injections. Furthermore, rising osteoarthritis and musculoskeletal disorders are expected to drive market growth.

Increase in prevalance of arthritis in the market will drive the market growth 

The extension of the joint pain injections market is predicted to be influenced by rising incidences of joint pain in developed and emerging nations and the rapid development of injections that allow doctors to analyze the fundamental causes of pain and aid in reducing pain swiftly. The facet joint injections contain a portion of an anesthetic drug, which numbs the muscles, ligaments, and articular capsules. Increased demand for non-surgical care has been identified as a key element promoting facet joint injections output during the predicted period. Furthermore, it is predicted to contribute to the total build-up of the facet joint injection during the evaluation time, improving the focus on effective pain relief.

Arthritis is the biggest cause of disability among adults in the United States, according to the Arthritis Foundation. Approximately 54 million people and 300,000 newborns and toddlers have arthritis or another rheumatic disease in the US. By 2040, more than 78 million people in the US would have been diagnosed with arthritis. In addition, osteoarthritis is the most common type of arthritis, affecting over 31 million people in the United States. The rising prevalence of arthritis is expected to raise demand for disease-modifying treatments, propelling the joint pain injections market during the forecast period.

&nbsp;Obesity is linked to various joint problems, particularly those affecting the knee, such as knee discomfort and osteoarthritis. Global obesity has tripled since 1975, according to a fact sheet provided by the World Health Organization (WHO). In 2016, 1.9 bn people were overweight, with over 650 million adults falling into this category. Furthermore, in 2017, approximately 41 million children under five were obese. According to the 2015-2016 National Health and Nutrition Examination Survey (NHANES), more than one out of every four children of Hispanic descent aged 2 to 19 had obesity, and nearly half of all adults had obesity.

&nbsp;Arthritis is the cause of joint discomfort in the general population and a major source of disability and reduced mobility. Treatment options now available are insufficient because they largely focus on symptom alleviation and pain management. There are no medications that can cure, reverse, or stop the progression of diseases like osteoarthritis. Furthermore, some people are unable to get relief from present treatments and continue to be in pain, indicating significant unmet requirements among patients with joint discomfort. This opens up the market for advanced therapeutic options for joint pain injections.This contributes to the growth of the global joint pain injections&nbsp;&nbsp; &nbsp;market.

Lack of awareness about the injections or treatment is likely to hamper the market growth 

The general public is unaware of joint pain injections. Hyaluronic acid injections, corticosteroid injections, and platelet-rich plasma injections are all used to treat joint discomfort. The use of these injections necessitates a thorough understanding and training. Doctors and healthcare professionals are primarily responsible for administering joint pain injections to patients. Professionals are given the necessary tools and training to accomplish this. The lack of government measures to promote joint pain injections is a barrier to the market&#39;s growth. As a result, lack of product awareness would pose a significant hurdle to the joint pain injections market&#39;s growth throughout the forecast period.

<h2>COVID-19 Impact Analysis</h2>

COVID-19&#39;s appearance greatly impacted the global demand for joint pain injections. As a result of the COVID-19 epidemic, leading players in the industry have reported a drop in revenue from joint pain injection sales. The fall in revenue for the joint pain injections sector has been ascribed to a decrease in patient visits, reallocation of healthcare resources for COVID-19 management, and disruption in the supply chain of key market competitors. In addition, non-covid-related activities and elective surgical procedures, such as operations to relieve joint discomfort, were postponed by healthcare facilities. For example, according to a study published in the Journal of Bone and Joint Surgery, 72.6 percent of institutions impeded orthopedic surgeons&#39; daily duties during the first half of 2020. According to the report, around half of the orthopedic practitioners were switched from conventional orthopedic work to COVID-19 patient treatment. Furthermore, because of the lockdown limitations in major markets for joint pain injections, commercial activities such as production and shipping were disrupted.

<h2>Segment Analysis</h2>

The hyaluronic acid injections segment is expected to grow at the fastest CAGR during the forecast period (2022-2029)&nbsp; &nbsp;&nbsp;&nbsp;

The hyaluronic acid injection is the market leader in the joint pain injections area. Because human joints are continually subjected to wear and tear, hyaluronic acid, like synovial fluid, has great lubricating and shock-absorbing qualities, minimizing joint stiffness and discomfort. Corticosteroid injections are an adjuvant drug in joint pain because of their anti-inflammatory qualities and capacity to provide short-term relief in joint sprains suffered by sports and industrial workers. Thus, the rising demand for hyaluronic acid injections throughout the projected period would expand the joint pain injections market.

Furthermore, According to a rapid response report published by Candian Agency for Drug and Technologies in Health, viscosupplementation with hyaluronic acid is superior to intra-articular placebo and other conventional medications, such as non-steroidal anti-inflammatory drugs (NSAIDs), in terms of improving knee pain and function with minimal adverse effects in adults with knee osteoarthritis.

<h2>Geographical Analysis</h2>

North America region holds the largest market share of global joint pain injections&nbsp;&nbsp; market

North America is likely to influence the market because of the high frequency of musculoskeletal problems that cause joint aches. Increased public knowledge of non-invasive orthopedic therapies, ongoing implant technology innovation, and sophisticated healthcare facilities.

According to the&nbsp; Center for Disease Control and Prevention, chronic pain caused by arthritis affects millions of people in the US each year according to the&nbsp; Center for Disease Control and Prevention. About one in every four persons has arthritis, and 15 million people say they have significant joint pain due to it. A high rate of advanced technology adoption is also one of the reasons driving the market&#39;s growth in this area. Furthermore, prominent market competitors are investing heavily in research, which will ultimately boost the market in North America. Furthermore, the presence of many key players in North America is a major factor driving market growth.

However, Asia-Pacific is assessed to grow the fastest during the forecast period, owing to increased healthcare spending and increased public knowledge of non-invasive orthopedic therapies, ongoing implant technology innovation, and sophisticated healthcare facilities which contribute to the growth of the Asia-Pacific joint pain injections market.

<h2>Competitive Landscape</h2>

The joint pain injections market is highly competitive with presence of local as well as global companies. &nbsp;Some of the key players which are contributing to the growth of the market include <a href="https://anika.com/medical/products/tactoset/">Anika Therapeutics Inc</a>, <a href="https://www.bioventus.com/products/">Bioventus</a>, <a href="https://www.ferring.com/science-innovation/research-and-development/">Ferring Pharmaceuticals Inc</a>, Sanofi SA, Pfizer Inc, Eli Lilly and Company, Flexion Therapeutics Inc, Teva Pharmaceuticals, Zimmer Biomet, Dr.Reddy Laboratories. The major players are adopting several growth strategies such as product launches, acquisitions, and collaborations, which are contributing to the growth of the joint pain injections market globally. For instance in July 2019, Teva Pharmaceutical Industries Ltd. declared the launch of 1% Sodium Hyaluronate in the US market following approval from the US FDA&#39;s Center for Devices and Radiological Health. This product is used to treat pain associated with knee osteoarthritis.

Key Developments

<ul>
	<li>In Nov 2020, Durolane, GELSYN-3, and SUPARTZ FX were added to the CVS Caremark Formulary by Bioventus Inc. It is used to treat osteoarthritis pains, and its inclusion will allow patients to learn about drug coverage terms.</li>
	<li>In Dec 2019, Flexion Therapeutics Inc announced the approval of a supplemental New Drug Application by the US Food and Drug Administration to update the product label of ZILRETTA and provide more specific information about the product.</li>
	<li>In July 2019, Teva Pharmaceutical Industries Ltd. declared the launch of 1% Sodium Hyaluronate in the US market following approval from the US FDA&#39;s Center for Devices and Radiological Health. This product is used to treat pain associated with knee osteoarthritis.</li>
</ul>

Bioventus 

Overview: Bioventus Inc is a company that specializes in medical technology. The company is involved in the development and commercialization of orthobiologic products to treat patients with a wide range of musculoskeletal conditions. Ultrasound Bone Healing, Joint Therapies, and Bioventus Surgical are some of the company&#39;s products.

Product Portfolio:

Durolane:&nbsp; Durolane is alike to the fluid that surrounds your body&#39;s joints. This fluid serves as a lubricant and a shock absorber for the joints. Durolane is used to treat osteoarthritic knee pain. Durolane is typically prescribed when other arthritis medications have failed to provide relief.

Why Purchase the Report?

<ul>
	<li>Visualize the composition of the global joint pain injections market segmentation by product ,injection types, joint type, end user, and region highlighting the key commercial assets and players.</li>
	<li>Identify commercial opportunities in global joint pain injections market by analyzing trends and co-development deals. &nbsp;</li>
	<li>Excel data sheet with thousands of data points of global joint pain injections market- level 4/5 segmentation.</li>
	<li>PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.&nbsp;</li>
	<li>Product mapping in excel for the key product of all major market players</li>
</ul>

The global joint pain injections market report would provide an access to an approximately 40+ market data table, 45+ figures and 175 pages. 

Target Audience

<ul>
	<li>Service Providers/ Buyers</li>
	<li>Industry Investors/Investment Bankers</li>
	<li>Education &amp; Research Institutes</li>
	<li>Research Professionals</li>
	<li>Emerging Companies</li>
	<li>Manufacturers</li>
</ul>

<h3 style="background:#eeeeee; border:1px solid #cccccc; padding:5px 10px">Trending Topics</h3>

<a href="https://www.datamintelligence.com/research-report/facial-injections-market">Facial Injections Market</a>

&nbsp;

<h2 style="background:#eeeeee; border:1px solid #cccccc; padding:5px 10px">Table of Contents</h2>

<ol>
	<li>Methodology and Scope

	<ol>
		<li>Research Methodology</li>
		<li>Research Objective and Scope of the Report</li>
	</ol>
	</li>
	<li>Market Definition and Overview</li>
	<li>Executive Summary
	<ol>
		<li>Market Snippet by &nbsp;Product</li>
		<li>Market Snippet by Injection Type</li>
		<li>Market Snippet by Joint Type</li>
		<li>Market Snippet by End User</li>
		<li>Market Snippet by Region</li>
	</ol>
	</li>
	<li>Market Dynamics
	<ol>
		<li>Market Impacting Factors
		<ol>
			<li>Drivers
			<ol>
				<li>Growing prevalence of arthritis and geriatric population worldwide.</li>
				<li>Increasing demand for knee pain injections.</li>
			</ol>
			</li>
			<li>Restraints:
			<ol>
				<li>High cost of injections</li>
				<li>&nbsp;Lack of awareness about the injections will hinder the growth of the market</li>
			</ol>
			</li>
			<li>Opportunity</li>
			<li>Impact Analysis</li>
		</ol>
		</li>
	</ol>
	</li>
	<li>Industry Analysis
	<ol>
		<li>Porter&#39;s Five Forces Analysis</li>
		<li>Supply Chain Analysis</li>
		<li>Pricing Analysis</li>
		<li>Regulatory Analysis</li>
		<li>Reimbursement Analysis</li>
	</ol>
	</li>
	<li>COVID-19 Analysis
	<ol>
		<li>Analysis of Covid-19 on the Market
		<ol>
			<li>Before COVID-19 Market Scenario</li>
			<li>Present COVID-19 Market Scenario</li>
			<li>After COVID-19 or Future Scenario</li>
		</ol>
		</li>
		<li>Pricing Dynamics Amid Covid-19</li>
		<li>Demand-Supply Spectrum</li>
		<li>Government Initiatives Related to the Market During Pandemic</li>
		<li>Manufacturers Strategic Initiatives</li>
		<li>Conclusion&nbsp;</li>
	</ol>
	</li>
	<li>By Product
	<ol>
		<li>Introduction
		<ol>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Segment</li>
			<li>Market Attractiveness Index, By Product Segment</li>
		</ol>
		</li>
		<li>Pre-filled injections*
		<ol>
			<li>Introduction</li>
			<li>Market Size Analysis, US$ Million, 2018-2028 and Y-o-Y Growth Analysis (%), 2020-2028</li>
		</ol>
		</li>
		<li>Vials</li>
	</ol>
	</li>
	<li>By Injection Type
	<ol>
		<li>Introduction
		<ol>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Injection Type</li>
			<li>Market Attractiveness Index, By Injection Type</li>
		</ol>
		</li>
		<li>Corticosteroid Injections*
		<ol>
			<li>Introduction</li>
			<li>Market Size Analysis, US$ Million, 2018-2028 and Y-o-Y Growth Analysis (%), 2020-2028</li>
		</ol>
		</li>
		<li>Hyaluronic Acid Injections</li>
		<li>Platelete Rich Plasma Injections</li>
		<li>Others</li>
	</ol>
	</li>
	<li>By Joint Type
	<ol>
		<li>&nbsp;Introduction
		<ol>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Joint Type</li>
			<li>Market Attractiveness Index, By Joint Type</li>
		</ol>
		</li>
		<li>Knee and Ankle*
		<ol>
			<li>Introduction</li>
			<li>Market Size Analysis, US$ Million, 2018-2028 and Y-o-Y Growth Analysis (%), 2020-2028</li>
			<li>Hip</li>
			<li>Shoulder and Elbow</li>
			<li>Others</li>
		</ol>
		</li>
	</ol>
	</li>
	<li>&nbsp;By End User
	<ol>
		<li>Introduction</li>
		<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User</li>
		<li>Market Attractiveness Index, By End User Segment
		<ol>
			<li>Hospitals Pharmacies*
			<ol>
				<li>Introduction</li>
				<li>Market Size Analysis, US$ Million, 2018-2028 and Y-o-Y Growth Analysis (%), 2020-2028</li>
			</ol>
			</li>
			<li>Online Pharmacies</li>
			<li>Retail Pharmacies</li>
			<li>Others</li>
		</ol>
		</li>
	</ol>
	</li>
	<li>By Region
	<ol>
		<li>Introduction
		<ol>
			<li>Market Size Analysis, US$ Million, 2018-2028 and Y-o-Y Growth Analysis (%), 2020-2028, By Region</li>
			<li>Market Attractiveness Index, By Region</li>
		</ol>
		</li>
		<li>North America
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Injection Type</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Joint Type</li>
			<li>Market Size Analysis ,and Y-o-Y Growth Analysis (%), By End User</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
			<ol>
				<li>U.S.</li>
				<li>Canada</li>
				<li>Mexico</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>Europe
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Injection Type</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Joint Type</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%),By End User</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country</li>
			<li>
			<ol>
				<li>Germany</li>
				<li>U.K.</li>
				<li>France</li>
				<li>Italy</li>
				<li>Spain</li>
				<li>Rest of Europe</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>South America
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Injection Type</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Joint Type</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
			<ol>
				<li>Brazil</li>
				<li>Argentina</li>
				<li>Rest of South America</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>Asia Pacific
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Injection Type</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%),By Joint Type</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
			<ol>
				<li>China</li>
				<li>India</li>
				<li>Japan</li>
				<li>Australia</li>
				<li>Rest of Asia Pacific</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>Middle East and Africa
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Injection Type</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Joint Type</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User</li>
		</ol>
		</li>
	</ol>
	</li>
	<li>Competitive Landscape
	<ol>
		<li>Key Developments and Strategies</li>
		<li>Company Share Analysis</li>
		<li>Product Benchmarking</li>
		<li>Key Companies to Watch</li>
	</ol>
	</li>
	<li>Company Profiles
	<ol>
		<li>Bioventus*
		<ol>
			<li>Company Overview</li>
			<li>Product Portfolio and Description</li>
			<li>Key Highlights</li>
			<li>Financial Overview Product Portfolio and Description</li>
			<li>Key Highlights</li>
			<li>Financial Overview</li>
		</ol>
		</li>
		<li>Anika Therapeutics Inc</li>
		<li>Ferring Pharmaceuticals Inc</li>
		<li>Sanofi SA</li>
		<li>Pfizer Inc</li>
		<li>Eli Lilly and Company</li>
		<li>Flexion Therapeutics Inc</li>
		<li>Teva Pharmaceuticals</li>
		<li>Zimmer Biomet</li>
		<li>Dr.Reddy Laboratories(*LIST NOT EXHAUSTIVE)</li>
	</ol>
	</li>
	<li>DataM Intelligence
	<ol>
		<li>Appendix</li>
		<li>About Us and Services</li>
		<li>Contact Us</li>
	</ol>
	</li>
</ol>

<h2 style="background:#eeeeee; border:1px solid #cccccc; padding:5px 10px">List of Tables &amp; Figures</h2>

List of Tables

Table 01 Global Join Pain Injections Market Value, By Product, 2021, 2025 &amp; 2029 ($ Million)

Table 02 Global Join Pain Injections Market Value, By Injection Type, 2021, 2025 &amp; 2029 ($ Million)

Table 03 Global Join Pain Injections Market Value, By Joint Type, 2021, 2025 &amp; 2029 ($ Million)

Table 04&nbsp; Global Join Pain Injections Market Value, By End-User , 2021, 2025 &amp; 2029 ($ Million)

Table 05 Global Join Pain Injections Market Value, By Region, 2021, 2025 &amp; 2029 ($ Million)

Table 06&nbsp; Global Join Pain Injections Market Value, By Product, 2021, 2025 &amp; 2029 ($ Million)

Table 07 Global Join Pain Injections Market Value, By Product, 2020-2029 ($ Million)

Table 08&nbsp; Global Join Pain Injections Market Value, By Injection Type, 2021, 2025 &amp; 2029 ($ Million)

Table 09&nbsp; Global Join Pain Injections Market Value, By Injection Type, 2020-2029 ($ Million)

Table 10 Global Join Pain Injections Market Value, By Joint Type, 2021, 2025 &amp; 2029 ($ Million)

Table 11&nbsp; Global Join Pain Injections Market Value, By Joint Type, 2020-2029 ($ Million)

Table 12 Global Join Pain Injections Market Value, By End-User , 2021, 2025 &amp; 2029 ($ Million)

Table 13 Global Join Pain Injections Market Value, By End-User , 2020-2029 ($ Million)

Table 14 Global Join Pain Injections Market Value, By Region, 2021, 2025 &amp; 2029 ($ Million)

Table 15 Global Join Pain Injections Market Value, By Region, 2020-2029 ($ Million)

Table 16 North America Join Pain Injections Market Value, By Product, 2020-2029 ($ Million)

Table 17 North America Join Pain Injections Market Value, By Injection Type, 2020-2029 ($ Million)

Table 18 North America Join Pain Injections Market Value, By Joint Type, 2020-2029 ($ Million)

Table 19 North America Join Pain Injections Market Value, By End-User , 2020-2029 ($ Million)

Table 20 North America Join Pain Injections Market Value, By Country, 2020-2029 ($ Million)

Table 21 South America Join Pain Injections Market Value, By Product, 2020-2029 ($ Million)

Table 22 South America Join Pain Injections Market Value, By Injection Type, 2020-2029 ($ Million)

Table 23 South America Join Pain Injections Market Value, By Joint Type, 2020-2029 ($ Million)

Table 24 South America Join Pain Injections Market Value, By End-User , 2020-2029 ($ Million)

Table 25 South America Join Pain Injections Market Value, By Country, 2020-2029 ($ Million)

Table 26 Europe Join Pain Injections Market Value, By Product, 2020-2029 ($ Million)

Table 27 Europe Join Pain Injections Market Value, By Injection Type, 2020-2029 ($ Million)

Table 28 Europe Join Pain Injections Market Value, By Joint Type, 2020-2029 ($ Million)

Table 29 Europe Join Pain Injections Market Value, By End-User , 2020-2029 ($ Million)

Table 30 Europe Join Pain Injections Market Value, By Country, 2020-2029 ($ Million)

Table 31 Asia-Pacific Join Pain Injections Market Value, By Product, 2020-2029 ($ Million)

Table 32 Asia-Pacific Join Pain Injections Market Value, By Injection Type, 2020-2029 ($ Million)

Table 33 Asia-Pacific Join Pain Injections Market Value, By Joint Type, 2020-2029 ($ Million)

Table 34 Asia-Pacific Join Pain Injections Market Value, By End-User , 2020-2029 ($ Million)

Table 35 Asia-Pacific Join Pain Injections Market Value, By Country, 2020-2029 ($ Million)

Table 36 Middle East &amp; Africa Join Pain Injections Market Value, By Product, 2020-2029 ($ Million)

Table 37 Middle East &amp; Africa Join Pain Injections Market Value, By Injection Type, 2020-2029 ($ Million)

Table 38 Middle East &amp; Africa Join Pain Injections Market Value, By Joint Type, 2020-2029 ($ Million)

Table 39 Middle East &amp; Africa Join Pain Injections Market Value, By End-User , 2020-2029 ($ Million)

Table 40&nbsp; Bioventus: Overview

Table 41 Bioventus: Product Portfolio

Table 42 Bioventus: Key Developments

Table 43 Anika Therapeutics Inc: Overview

Table 44&nbsp; Anika Therapeutics Inc: Product Portfolio

Table 45 Anika Therapeutics Inc: Key Developments

Table 46&nbsp; Ferring Pharmaceuticals Inc: Overview

Table 47 Ferring Pharmaceuticals Inc: Product Portfolio

Table 48&nbsp; Ferring Pharmaceuticals Inc: Key Developments

Table 49&nbsp; Sanofi SA: Overview

Table 50 Sanofi SA: Product Portfolio

Table 51 Sanofi SA: Key Developments

Table 52 Pfizer Inc: Overview

Table 53 Pfizer Inc: Product Portfolio

Table 54 Pfizer Inc: Key Developments

Table 55 Eli Lilly and Company: Overview

Table 56 Eli Lilly and Company: Product Portfolio

Table 57 Eli Lilly and Company: Key Developments

Table 58 Flexion Therapeutics Inc: Overview

Table 59 Flexion Therapeutics Inc: Product Portfolio

Table 60&nbsp; Flexion Therapeutics Inc: Key Developments

Table 61 Teva Pharmaceutical Industries Ltd: Overview

Table 62 Teva Pharmaceutical Industries Ltd: Product Portfolio

Table 63 Teva Pharmaceutical Industries Ltd: Key Developments

Table 64&nbsp; Zimmer Biomet: Overview

Table 65 Zimmer Biomet: Product Portfolio

Table 66&nbsp; Zimmer Biomet: Key Developments

Table 67 Dr.Reddy Laboratories: Overview

Table 68&nbsp; Dr.Reddy Laboratories: Product Portfolio

Table 69&nbsp; Dr.Reddy Laboratories: Key Developments

List of Figures

Figure 01 Global Join Pain Injections Market Share, By Product, 2021 &amp; 2029 (%)

Figure 02 Global Join Pain Injections Market Share, By Injection Type, 2021 &amp; 2029 (%)

Figure 03 Global Join Pain Injections Market Share, By Joint Type, 2021 &amp; 2029 (%)

Figure 04 Global Join Pain Injections Market Share, By End-User , 2021 &amp; 2029 (%)

Figure 05 Global Join Pain Injections Market Share, By Region, 2021 &amp; 2029 (%)

Figure 06 Global Join Pain Injections Market Value, 2020-2029 ($ Million)

Figure 07 Global Join Pain Injections Market Y-o-Y Growth, By Product, 2021-2029 (%)

Figure 08 Pre filled injections: Global Join Pain Injections Market Value, 2020-2029 ($ Million)

Figure 09 Vials: Global Join Pain Injections Market Value, 2020-2029 ($ Million)

Figure 10 Global Join Pain Injections Market Y-o-Y Growth, By Injection Type, 2021-2029 (%)

Figure 11&nbsp; Corticosteroid Injections: Global Join Pain Injections Market Value, 2020-2029 ($ Million)

Figure 12&nbsp; Hyaluronic Acid Injections: Global Join Pain Injections Market Value, 2020-2029 ($ Million)

Figure 13&nbsp; Platelete Rich Plasma Injections: Global Join Pain Injections Market Value, 2020-2029 ($ Million)

Figure 14 Others: Global Join Pain Injections Market Value, 2020-2029 ($ Million)

Figure 15&nbsp; Others: Global Join Pain Injections Market Value, 2020-2029 ($ Million)

Figure 16 Global Join Pain Injections Market Y-o-Y Growth, By Joint Type, 2021-2029 (%)

Figure 17&nbsp; Knee and Ankle: Global Join Pain Injections Market Value, 2020-2029 ($ Million)

Figure 18 Shoulder and Elbow: Global Join Pain Injections Market Value, 2020-2029 ($ Million)

Figure 19 Hip: Global Join Pain Injections Market Value, 2020-2029 ($ Million)

Figure 20 Others: Global Join Pain Injections Market Value, 2020-2029 ($ Million)

Figure 21&nbsp; Global Join Pain Injections Market Y-o-Y Growth, By End-User , 2021-2029 (%)

Figure 22 Hospitals Pharmacies: Global Join Pain Injections Market Value, 2020-2029 ($ Million)

Figure 23 Online Pharmacie: Global Join Pain Injections Market Value, 2020-2029 ($ Million)

Figure 24 Retail Pharmacies: Global Join Pain Injections Market Value, 2020-2029 ($ Million)

Figure 25 Others: Global Join Pain Injections Market Value, 2020-2029 ($ Million)

Figure 26 Global Join Pain Injections Market Y-o-Y Growth, By Region, 2021-2029 (%)

Figure 27 North America Join Pain Injections Market Value, 2020-2029 ($ Million)

Figure 28 North America Join Pain Injections Market Share, By Product, 2021 &amp; 2029 (%)

Figure 29 North America Join Pain Injections Market Share, By Injection Type, 2021 &amp; 2029 (%)

Figure 30 North America Join Pain Injections Market Share, By Joint Type, 2021 &amp; 2029 (%)

Figure 31&nbsp; North America Join Pain Injections Market Share, By End-User , 2021 &amp; 2029 (%)

Figure 32 North America Join Pain Injections Market Share, By Country, 2021 &amp; 2029 (%)

Figure 33 South America Join Pain Injections Market Value, 2020-2029 ($ Million)

Figure 34 South America Join Pain Injections Market Share, By Product, 2021 &amp; 2029 (%)

Figure 35 South America Join Pain Injections Market Share, By Injection Type, 2021 &amp; 2029 (%)

Figure 36 South America Join Pain Injections Market Share, By Joint Type, 2021 &amp; 2029 (%)

Figure 37 South America Join Pain Injections Market Share, By End-User , 2021 &amp; 2029 (%)

Figure 38 South America Join Pain Injections Market Share, By Country, 2021 &amp; 2029 (%)

Figure 39 Europe Join Pain Injections Market Value, 2020-2029 ($ Million)

Figure 40 Europe Join Pain Injections Market Share, By Product, 2021 &amp; 2029 (%)

Figure 41 Europe Join Pain Injections Market Share, By Injection Type, 2021 &amp; 2029 (%)

Figure 42 Europe Join Pain Injections Market Share, By Joint Type, 2021 &amp; 2029 (%)

Figure 43 Europe Join Pain Injections Market Share, By End-User , 2021 &amp; 2029 (%)

Figure 44 Europe Join Pain Injections Market Share, By Country, 2021 &amp; 2029 (%)

Figure 45 Asia-Pacific Join Pain Injections Market Value, 2020-2029 ($ Million)

Figure 46 Asia-Pacific Join Pain Injections Market Share, By Product, 2021 &amp; 2029 (%)

Figure 47 Asia-Pacific Join Pain Injections Market Share, By Injection Type, 2021 &amp; 2029 (%)

Figure 48 Asia-Pacific Join Pain Injections Market Share, By Joint Type, 2021 &amp; 2029 (%)

Figure 49 Asia-Pacific Join Pain Injections Market Share, By End-User , 2021 &amp; 2029 (%)

Figure 50 Asia-Pacific Join Pain Injections Market Share, By Country, 2021 &amp; 2029 (%)

Figure 51&nbsp; Middle East &amp; Africa Join Pain Injections Market Value, 2020-2029 ($ Million)

Figure 52 Middle East &amp; Africa Join Pain Injections Market Share, By Product, 2021 &amp; 2029 (%)

Figure 53 Middle East &amp; Africa Join Pain Injections Market Share, By Injection Type, 2021 &amp; 2029 (%)

Figure 54 Middle East &amp; Africa Join Pain Injections Market Share, By Joint Type, 2021 &amp; 2029 (%)

Figure 55 Middle East &amp; Africa Join Pain Injections Market Share, By End-User , 2021 &amp; 2029 (%)

Figure 56 Bioventus: Financials

Figure 57 Anika Therapeutics Inc: Financials

Figure 58 Ferring Pharmaceuticals Inc: Financials

Figure 59 Sanofi SA: Financials

Figure 60 Pfizer Inc: Financials

Figure 61 Eli Lilly and Company: Financials

Figure 62 Flexion Therapeutics Inc: Financials

Figure 63 Teva Pharmaceutical Industries Ltd: Financials

Figure 64 Zimmer Biomet: Financials

Figure 65 Dr.Reddy Laboratories: Financials